Drugs / Halobetasol Proprionate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01166646 | Jul 2010 → Jul 2011 | psoriasis | Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Halobetasol Proprionate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01166646 ↗ |